ampelopsin has been researched along with Osteosarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, N; Huang, W; Lu, M; Zhao, J; Zhou, G | 1 |
| Li, B; Liu, C; Wang, L; Xu, X; Yang, Y; Zhao, P | 1 |
| Chou, CH; Hsieh, YH; Lin, CW; Lu, KH; Yang, JS; Yang, SF | 1 |
| Jia, Q; Kang, T; Lu, J; Shen, J; Song, G; Tang, Q; Wang, J; Wang, Y; Wu, MS; Wu, Y; Xie, XB; Yin, JQ; Zhao, Z; Zou, C | 1 |
4 other study(ies) available for ampelopsin and Osteosarcoma
| Article | Year |
|---|---|
The flavonoid ampelopsin inhibited cell growth and induced apoptosis and G0/G1 arrest in human osteosarcoma MG-63 cells in vitro.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flavonoids; G1 Phase; Humans; Osteosarcoma; Resting Phase, Cell Cycle | 2015 |
Ampelopsin suppresses TNF-α-induced migration and invasion of U2OS osteosarcoma cells.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Flavonoids; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Tumor Necrosis Factor-alpha | 2016 |
Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Flavonols; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Osteosarcoma; Sp1 Transcription Factor; Urokinase-Type Plasminogen Activator | 2021 |
Dihydromyricetin activates AMP-activated protein kinase and P38(MAPK) exerting antitumor potential in osteosarcoma.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Line, Tumor; Flavonols; Fluorescent Antibody Technique; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Real-Time Polymerase Chain Reaction; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |